Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan + levamlodipine vs valsartan in mild to moderate primary hypertension
CTR20233802Phase 3Completed
- Sponsor
- Hemukang Pharmaceutical
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan + levamlodipine in essential hypertension, sponsored by Hemukang Pharmaceutical. Started Jan 2024; status: completed.
02
Drugs
valsartan + levamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20233802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233802.